Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02649894 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, MPEs Versus Approved Pleural Catheter
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
NCT02649894: Completed NA study, sponsored by C. R. Bard.
NCT02649894 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 119 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02649894, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a new catheter is safe and effective in treating malignant pleural effusions compared to approve catheter.
Interventions
- DEVICE Active Comparator: Approved Uncoated PleurX Indwelling Pleural Catheter
- DEVICE Experimental: Silver Nitrate Coated Indwelling Pleural Catheter (SNCIPC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-04-18 |
| Phase | NA |
What the finished NCT02649894 record still lists
NCT02649894 is an interventional study that assigns participants to a tested intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Active Comparator: Approved Uncoated PleurX Indwelling Pleural Catheter is the first listed.
NCT02649894 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02649894 about?
NCT02649894 is a clinical study titled "Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, MPEs Versus Approved Pleural Catheter". The purpose of this study is to determine whether a new catheter is safe and effective in treating malignant pleural effusions compared to approve catheter.
What is the current status of trial NCT02649894?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2016-05. Estimated completion is 2018-04-18.
What interventions are being tested in trial NCT02649894?
The interventions under investigation include: Active Comparator: Approved Uncoated PleurX Indwelling Pleural Catheter (DEVICE), Experimental: Silver Nitrate Coated Indwelling Pleural Catheter (SNCIPC) (DEVICE).
Who is sponsoring clinical trial NCT02649894?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02649894's enrollment target sits among peer trials
119 803rd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia